Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.Richard Görlick, Barry Anderson, Peter M. Anderson et al.|PubMed|2003Cited by 198
Predominant Nuclear Localization of Mammalian Target of Rapamycin in Normal and Malignant Cells in CultureXiongwen Zhang, Peter J. Houghton|Journal of Biological Chemistry|2002Cited by 127
Myogenic Differentiation Is Dependent on Both the Kinase Function and the N-terminal Sequence of Mammalian Target of RapamycinLili Shu, Peter J. Houghton|Journal of Biological Chemistry|2002Cited by 62
Targeting Glycoprotein NMB With Antibody‐Drug Conjugate, Glembatumumab Vedotin, for the Treatment of OsteosarcomaMichael Roth, Richard Görlick, David M. Barris et al.|Pediatric Blood & Cancer|2015Cited by 58
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in OsteosarcomaYu Cao, Richard Görlick, Pulivarthi H. Rao et al.|PLoS ONE|2014Cited by 47